Previous studies revealed that tumor necrosis factor-alpha (TNF-α) and interleukin-1-beta (IL-1β) are key mediators in the pathogenesis of NAFLD [23]. Here, IL1B is linked to metabolic dysfunction-associated steatotic liver disease.